Market Cap : 1.7 B | Enterprise Value : 1.54 B | PE Ratio : | PB Ratio : 18.66 |
---|
NAS:IMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immunogen's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2020 was $3.2 Mil.
Immunogen's quarterly Short-Term Capital Lease Obligation increased from Mar. 2020 ($3.1 Mil) to Jun. 2020 ($3.2 Mil) and increased from Jun. 2020 ($3.2 Mil) to Sep. 2020 ($3.2 Mil).
Immunogen's annual Short-Term Capital Lease Obligation stayed the same from Dec. 2017 ($0.0 Mil) to Dec. 2018 ($0.0 Mil) but then increased from Dec. 2018 ($0.0 Mil) to Dec. 2019 ($3.0 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.
No Headline